1 Fusionopolis Way
#20-10 Connexis North Tower
288 articles with A*STAR
Singapore scientists’ discovery could hold the key to novel treatments for the symptoms of mosquito-borne diseases
A*STAR Institute and Mayo Clinic Identify Key Protein to Convert Skin Cells into Other Types of C...
7/12/2018A*STAR’s Institute of Molecular & Cell Biology (IMCB) in Singapore, along with the Mayo Clinic, identified a key epigenetic protein called H3.3 that helps convert skin cells into other types of cells via cellular reprogramming.
A*STAR Release: New Study Links Genetic Diversity of Tumours With Resistance to Treatment in Asian Lung Cancer Patients
The study was published in the international journal Nature Communications.
A*STAR's Genome Institute of Singapore (GIS) Release: New Algorithm Predicts Treatment Targets for Cancer Using 'Wisdom of the Crowd'
Singapore scientists develop intelligent system that sifts through massive genetic datasets to pinpoint targets for cancer treatment
IBN Executive Director Professor Jackie Y. Ying Elected Fellow of the U.S. National Academy of Inventors
Prof Ying is the first researcher based in Singapore to receive this recognition.
A*STAR's Genome Institute of Singapore (GIS) :A Step Forward in Mending Damaged Lungs Using Stem Cells
New research has discovered a means to partially repair damaged lungs.
A*STAR IME's New Multi-Chip Fan-Out Wafer Level Packaging Development Line to Drive Innovation and Growth in Semiconductor Industry
The IoT is set to become the next growth driver for the semiconductor industry, as demand for internet-connected devices continues to soar.
Singaporean researchers have made significant inroads in the study of Ribonucleic Acid (RNA) editing.
A*STAR Release: Gene Mutation Discovered To Cause Severe Growth Retardation In Newly Discovered Disease
A*STAR Release: Breakthrough Findings Establish Fetal Immunity Develops As Early As Second Trimester Of Pregnancy
ROHM And A*STAR’s IME To Develop Artificial Intelligence Chip For Predictive Maintenance In Smart Factories
Chugai Pharma - A*STAR Joint Development Project For Anti-Dengue Virus Antibody Selected As Grant Recipient By The GHIT Fund